SPG vs SPRY · rev $3.55B vs rev $56.3M
SPG (SPG) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
SPG currently screens at market cap $0. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the SPG and SPRY stock pages for the full models.
Not investment advice.